On Tuesday, I-Mab ADR (NASDAQ: IMAB) was 5.71% up from the session before settling in for the closing price of $1.05. A 52-week range for IMAB has been $0.99 – $2.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 935.64% over the last five years. When this article was written, the company’s average yearly earnings per share was at 66.34%. With a float of $76.81 million, this company’s outstanding shares have now reached $77.02 million.
The firm has a total of 220 workers. Let’s measure their productivity. In terms of profitability, gross margin is 100.0%, operating margin of -5664.37%, and the pretax margin is -6335.6%.
I-Mab ADR (IMAB) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward I-Mab ADR stocks. The insider ownership of I-Mab ADR is 0.27%, while institutional ownership is 19.74%. The most recent insider transaction that took place on Jul 26 ’24, was worth 69,500.
I-Mab ADR (IMAB) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 66.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.00% during the next five years compared to -18.89% drop over the previous five years of trading.
I-Mab ADR (NASDAQ: IMAB) Trading Performance Indicators
You can see what I-Mab ADR (IMAB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 16.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 77.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.61 in one year’s time.
Technical Analysis of I-Mab ADR (IMAB)
Analysing the last 5-days average volume posted by the [I-Mab ADR, IMAB], we can find that recorded value of 0.27 million was lower than the volume posted last year of 0.32 million. As of the previous 9 days, the stock’s Stochastic %D was 45.45%. Additionally, its Average True Range was 0.07.
During the past 100 days, I-Mab ADR’s (IMAB) raw stochastic average was set at 11.88%, which indicates a significant decrease from 75.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.79% in the past 14 days, which was lower than the 57.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1945, while its 200-day Moving Average is $1.6272. Now, the first resistance to watch is $1.1333. This is followed by the second major resistance level at $1.1567. The third major resistance level sits at $1.1933. If the price goes on to break the first support level at $1.0733, it is likely to go to the next support level at $1.0367. Should the price break the second support level, the third support level stands at $1.0133.
I-Mab ADR (NASDAQ: IMAB) Key Stats
There are 80,883K outstanding shares of the company, which has a market capitalization of 85.49 million. As of now, sales total 3,890 K while income totals -206,440 K. Its latest quarter income was 0 K while its last quarter net income were 25,130 K.
